{
    "organizations": [],
    "uuid": "60644798b0dd64fa87bf07bf241265a763b0f2e5",
    "author": "",
    "url": "https://www.reuters.com/article/brief-celldex-therapeutics-reports-q1-lo/brief-celldex-therapeutics-reports-q1-loss-per-share-0-84-idUSASC0A1F3",
    "ord_in_thread": 0,
    "title": "BRIEF-Celldex Therapeutics Reports Q1 Loss Per Share $0.84",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10, 2018 / 12:13 PM / Updated 7 minutes ago BRIEF-Celldex Therapeutics Reports Q1 Loss Per Share $0.84 Reuters Staff\nMay 10 (Reuters) - Celldex Therapeutics Inc:\n* CELLDEX PROVIDES CORPORATE UPDATE AND REPORTS FIRST QUARTER 2018 RESULTS * Q1 REVENUE VIEW $2.3 MILLION — THOMSON REUTERS I/B/E/S\n* Q1 EARNINGS PER SHARE VIEW $-0.20 — THOMSON REUTERS I/B/E/S\n* CELLDEX - SEES CASH, CASH EQUIVALENTS, MARKETABLE SECURITIES AT MAR 31, PROCEEDS FROM SALES OF STOCK SUFFICIENT TO FUND OPERATIONS THROUGH 2020\n* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF MARCH 31, 2018 WERE $123.2 MILLION VERSUS $139.4 MILLION AS OF DEC 31, 2017 Source text for Eikon: Further company coverage:",
    "published": "2018-05-10T15:11:00.000+03:00",
    "crawled": "2018-05-10T15:26:28.008+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "report",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "may",
        "reuters",
        "celldex",
        "therapeutic",
        "inc",
        "celldex",
        "provides",
        "corporate",
        "update",
        "report",
        "first",
        "quarter",
        "result",
        "q1",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "celldex",
        "see",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "mar",
        "proceeds",
        "sale",
        "stock",
        "sufficient",
        "fund",
        "operation",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "march",
        "million",
        "versus",
        "million",
        "dec",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}